Starsource Multitrade

Starsource Multitrade Net Debt/Equity

Net Debt to Equity Ratio of Starsource Multitrade (506365.BO) as of Oct 27, 2026.

Net Debt/Equity

0.00

Last updated:

Net Debt to Equity Ratio of Starsource Multitrade is 2026 0.00 . Net Debt to Equity Ratio of Starsource Multitrade was 2025 -0.81 . It decreases by % higher compared to the previous year.

The Starsource Multitrade Net Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/Equity
Date
Net Debt/Equity
Jan 1, 2023
-0.52 INR
Jan 1, 2024
-0.48 INR
Jan 1, 2025
-0.81 INR
Jan 1, 2026
0.00 INR
The Starsource Multitrade Net Debt/Equity history
YEARNet Debt/EquityYoY
0.00-100.00%
-0.81+69.45%
-0.48-8.63%
-0.52—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's Starsource Multitrade with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Starsource Multitrade

All Key Metrics — Starsource Multitrade